Clinical Trial Management System Market to Reach Value of Approximately US$ 3.2 Billion by 2025
October 09, 2018 09:45 ET
|
Transparency Market Research
Albany, New York, Oct. 09, 2018 (GLOBE NEWSWIRE) -- The global market for clinical trial management system is considered as extremely consolidated in nature with a few players holding a huge share...
US$ 1 Billion Opportunity Emerges in the Clinical Trial Management Systems Market as Traditional Models Become Obsolete
June 11, 2018 06:27 ET
|
FACT.MR
Rockville, MD, June 11, 2018 (GLOBE NEWSWIRE) -- Highlights Clinical trial management systems market to surpass US$ 1 Bn during the review periodIncremental opportunity of US$ 116 Mn in...
(CTMS) Clinical Trial Management Systems Market worth over $2.4 billion by 2024: Global Market Insights, Inc.
April 23, 2018 05:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, April 23, 2018 (GLOBE NEWSWIRE) -- Clinical Trial Management Systems (CTMS) Market is poised to surpass USD 2.4 billion by 2024; according to a new research report by Global...
Clinical Trial Management System Market to Generate a Revenue of US$ 3.2 Bn by 2025 - TMR
April 18, 2018 02:33 ET
|
Transparency Market Research
Albany, NY, April 18, 2018 (GLOBE NEWSWIRE) -- The global clinical trial management system market was valued at over US$ 1.1 Bn in 2016 and is projected to expand at a cumulative annual growth rate...
Clinical Trial Management System (CTMS) Market worth 1,848.5 Million USD by 2019; Web-based CTMS Solutions in Demand in North America
September 27, 2016 08:15 ET
|
Transparency Market Research
Albany - New York, Sept. 27, 2016 (GLOBE NEWSWIRE) -- A new Transparency Market Research report states that the global clinical trial management system (CTMS) market was valued at US$844 mn in...
Central and Eastern Europe Building Clinical Trial Success
February 09, 2011 04:09 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - February 9, 2011) - Clinical trial sites in Central and Eastern Europe have high investigator standards and strong patient interest, making them a prime...